SI2185543T1 - Postopek za optiäśno loäśevanje soli omeprazola - Google Patents

Postopek za optiäśno loäśevanje soli omeprazola

Info

Publication number
SI2185543T1
SI2185543T1 SI200831258T SI200831258T SI2185543T1 SI 2185543 T1 SI2185543 T1 SI 2185543T1 SI 200831258 T SI200831258 T SI 200831258T SI 200831258 T SI200831258 T SI 200831258T SI 2185543 T1 SI2185543 T1 SI 2185543T1
Authority
SI
Slovenia
Prior art keywords
optical resolution
omeprazole salts
omeprazole
salts
resolution
Prior art date
Application number
SI200831258T
Other languages
English (en)
Inventor
Gerard Coquerel
Guillaume Tauvel
Marie-Noelle Petit
Original Assignee
Universite De Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite De Rouen filed Critical Universite De Rouen
Publication of SI2185543T1 publication Critical patent/SI2185543T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SI200831258T 2007-08-29 2008-08-29 Postopek za optiäśno loäśevanje soli omeprazola SI2185543T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0706058A FR2920428B1 (fr) 2007-08-29 2007-08-29 Procede de dedoublement de sels de l'omeprazole
EP08828432.8A EP2185543B1 (fr) 2007-08-29 2008-08-29 Procede de dedoublement optique de sels de l'omeprazole
PCT/FR2008/051547 WO2009027614A2 (fr) 2007-08-29 2008-08-29 Procede de dedoublement de sels de l'omeprazole

Publications (1)

Publication Number Publication Date
SI2185543T1 true SI2185543T1 (sl) 2014-11-28

Family

ID=39358134

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831258T SI2185543T1 (sl) 2007-08-29 2008-08-29 Postopek za optiäśno loäśevanje soli omeprazola

Country Status (10)

Country Link
US (1) US8034948B2 (sl)
EP (1) EP2185543B1 (sl)
JP (1) JP5656635B2 (sl)
CN (1) CN102131799B (sl)
CA (1) CA2697724C (sl)
DK (1) DK2185543T3 (sl)
ES (1) ES2493639T3 (sl)
FR (1) FR2920428B1 (sl)
SI (1) SI2185543T1 (sl)
WO (1) WO2009027614A2 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864794B1 (fr) * 2004-01-06 2006-05-19 Centre Nat Rech Scient Procede continu de cristallisation partielle d'une solution et dispositif de mise en oeuvre
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
WO2010097583A1 (en) * 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
CN102470158A (zh) * 2009-08-27 2012-05-23 默沙东公司 制备丙型肝炎病毒的蛋白酶抑制剂的工艺方法
FR2954310B1 (fr) 2009-12-18 2014-07-25 Univ Rouen Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle
FR2959509B1 (fr) * 2010-05-03 2012-07-13 Prod Chim Auxiliaires Et De Synthese Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole
CN102993184A (zh) * 2013-01-08 2013-03-27 湖南方盛制药股份有限公司 一种埃索美拉唑及其镁盐三水合物的制备方法
CN103524491A (zh) * 2013-10-16 2014-01-22 江南大学 埃索美拉唑镁盐四水合物的三种晶型及其制备方法
NZ714742A (en) 2014-04-16 2017-04-28 Signal Pharm Llc Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
CN104844572B (zh) * 2015-04-02 2017-06-20 天津大学 一种奥美拉唑钠1,2‑丙二醇溶剂化物及制备方法
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
SG11201912403SA (en) 2017-06-22 2020-01-30 Celgene Corp Treatment of hepatocellular carcinoma characterized by hepatitis b virus infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710337B1 (fr) * 1993-09-23 1995-12-08 Gerard Coquerel Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
SE9900274D0 (sv) * 1999-01-28 1999-01-28 Astra Ab New compound
EP1595879A3 (en) * 1999-08-26 2010-01-27 aaiPharma Inc. Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
SE0104295D0 (sv) * 2001-12-18 2001-12-18 Astrazeneca Ab New process
GB0219292D0 (en) * 2002-08-19 2002-09-25 Eisai London Res Lab Ltd Process
US7439367B2 (en) * 2003-01-15 2008-10-21 Cipla Limited Pharmaceutical process and compounds prepared thereby
PT1740571E (pt) * 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
WO2006131338A2 (en) * 2005-06-08 2006-12-14 Lek Pharmaceuticals D.D. Crystalline solvate of omeprazole sodium
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole

Also Published As

Publication number Publication date
WO2009027614A3 (fr) 2010-09-02
EP2185543A2 (fr) 2010-05-19
EP2185543B1 (fr) 2014-05-21
FR2920428B1 (fr) 2012-06-15
WO2009027614A2 (fr) 2009-03-05
CA2697724C (fr) 2017-03-14
JP5656635B2 (ja) 2015-01-21
US20090124811A1 (en) 2009-05-14
ES2493639T3 (es) 2014-09-12
FR2920428A1 (fr) 2009-03-06
CN102131799B (zh) 2014-06-18
DK2185543T3 (da) 2014-08-18
CN102131799A (zh) 2011-07-20
CA2697724A1 (fr) 2009-03-05
US8034948B2 (en) 2011-10-11
JP2010540413A (ja) 2010-12-24

Similar Documents

Publication Publication Date Title
SI2185543T1 (sl) Postopek za optiäśno loäśevanje soli omeprazola
GB2452668B (en) Optical apparatus
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
IL190089A0 (en) Process for using optical agents
TWI346294B (en) Method for correcting optical proximity effect
EP2346802A4 (en) PROCESS FOR DECONTAMINATING SYNGAS
EP2191328A4 (en) DEVICE FOR OPTICAL PROJECTIONS
EP2123631A4 (en) PROCESS FOR THE PREPARATION OF ALKOXYPROPIONAMIDE
IL202046A0 (en) Process for the manufacture of p4o6
EP2370797A4 (en) POLARIZED OPTICAL FOR OPTICAL DIAGNOSTIC DEVICE
EP2117330A4 (en) PROCESS FOR THE PREPARATION OF ANGIOGENIN
GB0811007D0 (en) Process for makign crystals
PL2151428T3 (pl) Nowy sposób syntezy agomelatyny
ZA200907191B (en) Process for the preparation of gefitiib
GB201006767D0 (en) Optical mouse
EP2195309A4 (en) SALT POLYMORPHS OF THE ESOMEPRAZOLE
GB0723561D0 (en) Optical apparatus
GB0820813D0 (en) Optical semiconductor apparatus
GB0721060D0 (en) Optical inspection
GB0822777D0 (en) Optical apparatus
PL2102174T3 (pl) Sposób wytwarzania pochodnych podstawionych cyjanofenoksy-pirymidynyloksyfenyloakrylanów
IL181485A0 (en) Processes for preparing novel montelukast salts
IL205082A0 (en) Process for the preparation of tetranorlabdane derivatives
EG26332A (en) Process for the preparation of benzonoprons
EP2203441A4 (en) PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS